Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4249836 | 0.91 | GRIN2B (0.40) | S1PR1S1PR5SIGMAR1ACHE | |
| SCHEMBL4248188 | 0.89 | ACHE (0.42) | MEN1KMT2AS1PR1S1PR5KDM4E | |
| SCHEMBL4238209 | 0.88 | PKM (0.42) | MEN1KMT2AS1PR1S1PR5SIGMAR1 | |
| SCHEMBL4242012 | 0.87 | ACHE (0.45) | MEN1KMT2AS1PR1S1PR5SIGMAR1 | |
| SCHEMBL4244909 | 0.86 | S1PR1 (0.44) | MEN1KMT2AS1PR1S1PR5S1PR4 | |
| SCHEMBL4237318 | 0.83 | SIGMAR1 (0.44) | MEN1KMT2AS1PR1S1PR5SIGMAR1 | |
| SCHEMBL4240892 | 0.83 | SIGMAR1 (0.42) | SIGMAR1DRD2ACHE | |
| SCHEMBL4242086 | 0.81 | MEN1 (0.42) | MEN1KMT2AS1PR1S1PR5SIGMAR1 | |
| SCHEMBL4248181 | 0.79 | ACHE (0.38) | MEN1KMT2AS1PR1S1PR5ACHE | |
| SCHEMBL4244048 | 0.78 | GRIN2B (0.37) | S1PR1S1PR5SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090012116-A1 | Muscarinic Receptor Antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012116-A1 | Muscarinic Receptor Antagonists | CHRM3, CHRM2, CHRM5 | MEN1 1950/4885KMT2A 2913/4885S1PR1 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.